Nigeria is managing its first confirmed case of Ebola virus disease in 12 years after laboratory tests identified an imported infection in a woman who had travelled from Uganda to Abuja. Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, announced the confirmation on October 20, 2026. The patient, described by health sources as the wife of a diplomat and not a Nigerian national, developed symptoms on October 7, four days after arriving in the country, and sought treatment at a private hospital in the Federal Capital Territory on October 11. The case is linked to the ongoing Ebola outbreak in parts of East Africa. The patient arrived in Abuja via Addis Ababa. Nigerian authorities have identified 44 close contacts for monitoring; these include healthcare workers, patients, caregivers, and travel contacts. The patient’s husband, a Swiss national, is among those being followed. As of late October, the Federal Government stated that the patient is in isolation, receiving care, and showing signs of clinical improvement. Minister Pate said laboratory results indicated significant progress and that full recovery was possible, while stressing that containment remained the priority and that nothing could be taken for granted. Nigeria last recorded an Ebola case during the 2014 West African epidemic, which the country successfully contained. The current situation has tested surveillance and response systems. The virus strain identified is Bundibugyo. Health authorities have activated emergency response measures, strengthened infection prevention and control at the treating facility, and intensified surveillance at points of entry. The Nigeria Centre for Disease Control (NCDC) and the FCT Health Services Secretariat are coordinating contact tracing and monitoring. Officials have urged the public not to panic and have advised against unnecessary physical contact while the situation is monitored. Public health experts have noted both strengths and challenges in the response. Nigeria demonstrated laboratory capacity to confirm the Bundibugyo strain relatively quickly once testing was ordered. However, the interval between the patient’s arrival, the onset of symptoms, presentation at a private hospital, and eventual Ebola testing has drawn attention to the need for continued vigilance at the primary-care level, especially when patients present with malaria-like symptoms after travel from affected regions. The outbreak in the Democratic Republic of Congo and surrounding areas has already been described by some regional health observers as one of the faster-spreading episodes in recent years, raising the possibility of a broader pan-African event if cases continue to move across regions. As of October 24, 2026, Nigerian authorities have reported no evidence of community transmission. Contact tracing remains active, and the government has ordered strict screening protocols at entry points. The NCDC has made its toll-free line (6232) available for public inquiries and suspected-case reporting. The case has prompted renewed discussion about border surveillance, the capacity of private hospitals to recognise travel-related risk, and the importance of rapid laboratory confirmation. The situation is being watched across the region. Nigeria’s large population, international air links, and previous experience containing Ebola in 2014 make its handling of this imported case a significant test of preparedness. Officials continue to emphasise that the single confirmed case remains isolated and that aggressive contact monitoring is the primary tool for preventing further spread. Updates from the Ministry of Health and the NCDC are expected as laboratory results and contact follow-up progress.